Galectin Therapeutics
GALT
GALT
55 hedge funds and large institutions have $53.9M invested in Galectin Therapeutics in 2014 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
61% less call options, than puts
Call options by funds: $3.35M | Put options by funds: $8.65M
Holders
55
Holding in Top 10
–
Calls
$3.35M
Puts
$8.65M
Top Buyers
| 1 | +$6.11M | |
| 2 | +$5.33M | |
| 3 | +$3.13M | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$3.06M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$2.48M |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$723K | |
| 3 | -$648K | |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$447K |
| 5 |
LOM
Loeb Offshore Management
New York
|
-$90K |